Detailansicht

Univ.-Prof. Mag. Dr. Markus Mitterhauser
T: +43-1-4277-52620
Kiss, A., Wu, P., Schlederer, M., Pilz, P. M., Szabo, P. L., Li, J., Weber, L., Vraka, C., Pichler, V., Mitterhauser, M., Zhang, X., Zins, K., Abraham, D., Li, S., Podesser, B. K., Hacker, M., & Li, X. (2022). Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning. Basic research in cardiology, 117(1), [42]. https://doi.org/10.1007/s00395-022-00946-3



Bencurova, K., Friske, J., Anderla, M., Mayrhofer, M., Wanek, T., Nics, L., Egger, G., Helbich, T. H., Hacker, M., Haug, A., Mitterhauser, M., & Balber, T. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging. Cancers, 14(22), [5549]. https://doi.org/10.3390/cancers14225549

Balber, T., Raitanen, J., Benčurová, K., Franssen, T., Schwarzl, P., Kalla, J., Culig, Z., Hacker, M., Egger, G., & Mitterhauser, M. (2022). In vitro investigation of a potential complementary expression of the imaging biomarkers AR and PSMA during prostate cancer progression. European Journal of Nuclear Medicine and Molecular Imaging, 49(SUPPL 1), S329-S330.

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2022). First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-D-aspartate Receptor with (R)-C-11-Me-NB1. Journal of Nuclear Medicine, 63(6), 936-941. https://doi.org/10.2967/jnumed.121.262427

Rasul, S., Beitzke, D., Wollenweber, T., Rausch, I., Lassen, M. L., Stelzmüller, M. E., Mitterhauser, M., Pichler, V., Beyer, T., Loewe, C., & Hacker, M. (2022). Assessment of left and right ventricular functional parameters using dynamic dual-tracer [13N]NH3 and [18F]FDG PET/MRI. Journal of Nuclear Cardiology, 29(3), 1003-1017. https://doi.org/10.1007/s12350-020-02391-y



Rischka, L., Murgaš, M., Pichler, V., Vraka, C., Rausch, I., Winkler, D., Nics, L., Rasul, S., Silberbauer, L. R., Reed, M. B., Godbersen, G. M., Unterholzner, J., Handschuh, P., Gryglewski, G., Mindt, T., Mitterhauser, M., Hahn, A., Ametamey, S. M., Wadsak, W., ... Hacker, M. (2022). Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1. EJNMMI Research, 12(1), [53]. https://doi.org/10.1186/s13550-022-00925-8


Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2021). First-in-human mapping of the GluN2B subunits of the N-methyl-D-aspartate receptor using (R)-[(11)Cc]Me-NB1 and PET. European Journal of Nuclear Medicine and Molecular Imaging, 48(SUPPL 1), 296.

Klebermass, E-M., Mahmudi, M., Geist, B. K., Pichler, V., Vraka, C., Balber, T., Miller, A., Haschemi, A., Viernstein, H., Rohr-Udilova, N., Hacker, M., & Mitterhauser, M. (2021). If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals, 14(9), [910]. https://doi.org/10.3390/ph14090910

Philippe, C., Klebermass, E-M., Balber, T., Kulterer, O. C., Zeilinger, M., Egger, G., Dumanic, M., Herz, C. T., Kiefer, F. W., Scheuba, C., Scherer, T., Fuernsinn, C., Vraka, C., Pallitsch, K., Spreitzer, H., Wadsak, W., Viernstein, H., Hacker, M., & Mitterhauser, M. (2021). Discovery of melanin-concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences, 1494(1), 70-86. https://doi.org/10.1111/nyas.14563


Hana, C. A., Klebermass, E. M., Balber, T., Mitterhauser, M., Quint, R., Hirtl, Y., Klimpke, A., Somloi, S., Hutz, J., Sperr, E., Eder, P., Jašprová, J., Valášková, P., Vítek, L., Heiss, E., & Wagner, K. H. (2021). Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Frontiers in Pharmacology, 11, [636533]. https://doi.org/10.3389/fphar.2020.636533




Baldinger-Melich, P., Gryglewski, G., Philippe, C., Murgaš, M., James, G. M., Vraka, C., Silberbauer, L., Balber, T., Vanicek, T., Pichler, V., Unterholzner, J., Kranz, G. S., Hahn, A., Winkler, D., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Frey, R., & Lanzenberger, R. (2020). Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation, 13(5), 1280-1281. https://doi.org/10.1016/j.brs.2020.06.009

Of Mice and Men - Applied Diagnostics

Markus Mitterhauser (Invited speaker)

4 Apr. 2022

Aktivität: VorträgeVortragScience to Science


A bone model for the reduction of future animal experiments?

Markus Mitterhauser (Vortragende*r)

10 Jan. 2008

Aktivität: VorträgeVortragAndere


Ist [68Ga]EDTMP brauchbar für Knochenscans?

Markus Mitterhauser (Vortragende*r)

25 Jan. 2007

Aktivität: VorträgeVortragAndere


A new model for the pre vivo-evaluation of bone seekers?

Markus Mitterhauser (Autor*in)

10 Jan. 2004

Aktivität: VorträgeVortragAndere


Institut für Anorganische Chemie

Währinger Straße 42
1090 Wien

T: +43-1-4277-52620

markus.mitterhauser@univie.ac.at